Therapeutic targeting of metabolic synthetic lethality in cancer research

Keynote - Cancer Immunology (Carl H. June)Подробнее

Synthetic Lethality in Cancer Therapeutics - OICR MondaysПодробнее

Opportunities and Challenges of Exploiting Synthetic Lethality in CancerПодробнее

Challenges associated with synthetic lethality in cancer therapeuticsПодробнее

Combining Epigenetic and Metabolic Approaches for Targeted Cancer TreatmentПодробнее

Targeting cancer cell metabolismПодробнее

Dr. Jeffrey Weitzel on Synthetic Lethality in BRCA-Associated CancerПодробнее

Synthetic Lethality | Revolutionizing Cancer TreatmentПодробнее

Drug Combinations for Synthetic Lethal Interactions | Protocol PreviewПодробнее

Discovery of Synthetic Lethal Paralog Pairs in the Human Genome | Phoebe ParrishПодробнее

Targeting mitochondrial metabolic pathways in glioblastoma therapyПодробнее

CRISPR screens to identify novel DNA repair defects synthetic lethal therapiesПодробнее

Targeting SMARCA4 mutations in lung cancerПодробнее

What is synthetic lethality?Подробнее

MRTX9768: a synthetic lethal-based inhibitor designed to bind the PRMT5•MTA complex and target M...Подробнее

The Role of Targeting DNA Repair with PARPПодробнее

Advancing cancer treatment by targeting dysregulated metabolism – A roadmapПодробнее

Stratification in Cancer Medicine - Matthew GarnettПодробнее

Cancer Metabolism: From molecules to medicineПодробнее